Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
1,015
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation
Deborah R. Kayea Duke University Cancer Center, Durham, NC, USA
, Ibrahim Khilfehb Janssen Scientific Affairs, LLC., Horsham, PA, USA
, Erik Muserb Janssen Scientific Affairs, LLC., Horsham, PA, USA
, Laura Morrisonc Analysis Group, Inc., Montréal, QC, Canada
, Frederic Kinkeadc Analysis Group, Inc., Montréal, QC, Canada
, Ana Urosevicc Analysis Group, Inc., Montréal, QC, Canada
, Patrick Lefebvrec Analysis Group, Inc., Montréal, QC, Canada
, Dominic Pilonc Analysis Group, Inc., Montréal, QC, CanadaCorrespondence[email protected]
& Daniel J. Georgea Duke University Cancer Center, Durham, NC, USA
show all
Pages 201-214
|
Received 28 Aug 2023, Accepted 08 Jan 2024, Published online: 02 Feb 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.